Company intelligence / Profile preview

Innomar Strategies

Oakville, Ontario, Canadainnomar-strategies.com ↗

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

Innomar Strategies provides end-to-end commercialization and patient support solutions for specialty pharmaceuticals in Canada. They have played a major role in COVID‑19 vaccine distribution and support over 100 specialty drugs across the country. No clinical results as they do not develop drugs.

Industry: Consulting

Partnerships

Partnerships with pharmaceutical manufacturershealthcare providerspharmaciespayers for patient access programs and logistics

Beyond the preview

Go deeper on Innomar Strategies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innomar Strategies.

Explore the full profile